Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT04110951
Eligibility Criteria:
Inclusion Criteria:
* Can communicate,
* To have an increase of %12 or 200 ml in FEV1 value after inhaler bronchodilator at breathing function test,
* To have chronic asthma diagnose with 6 months approved by doctors and receiving treatment,
* Asthma controls are not under control or partly under control in relation to GINA (Global Initiative for Asthma) values,
* Taking beta2-agonist and/or ICS twice a week or more to control asthma symptoms,
* There is not any chance in inhaler bronchodilator drug potions during the last four weeks,
* Can use a smart phone.
Exclusion Criteria:
* To have lung diseases such as COPD,
* To have tuberculosis and respiratory infection,
* To have diabetes and coronary artery disease,
* Smokers
* Pregnant or nursing mother,
* Doing regular exercise,
* Benefitng from other complementary and integrative health applications during treatments
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04110951
Study Brief:
Protocol Section:
NCT04110951